RecoverPC

A Phase 2 Study of Relugolix Versus GnRH Agonist Quality of Life (QOL) and Testosterone Recovery in Men with Prostate Cancer - NCT05765500

Objective

To compare QOL by Functional Assessment of Cancer Therapy - Prostate (FACT-P) questionnaire at 3 months after completing ADT between treatment arms

Principal Investigator(s):
Peter Ward, MD

Contact:
Meghan Stone, BHS, Clinical Research Coordinator at 508-862-7284

How to Participate:
Contact your oncologist, oncology nurse or the Oncology Research Program Manager.

Clinical Trial Categories

  • Treatment
  • Prostate Cancer